• No results found

pSTAT3: a target biomarker to study the pharmacology of the anti IL 21R antibody ATR 107 in human whole blood

N/A
N/A
Protected

Academic year: 2020

Share "pSTAT3: a target biomarker to study the pharmacology of the anti IL 21R antibody ATR 107 in human whole blood"

Copied!
9
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 (See legend on next page.)
Figure 2 ATR-107 behaves like a non-competitive antibody.removed by adding the BD Lyse/fix buffer
Figure 3 ATR-107 competes with IL-21 for receptor binding on naïve B-cells (CD19+CD27-)

References

Related documents

Likewise, there is a push from the federal government to evaluate programs using more conclusive empirical designs (U.S. Department of Education, 2003). As a result, the intention

Concerning the specific response to HBV vaccination, several additional factors contribute to an inefficient immune protection in chronic renal failure patients, such as advanced

Specifically, Section 8(a)(2) provides that “[i]t shall be an unfair labor practice for an employer to dominate or interfere with the formation or administration of any labor

This Note addresses the competing environmental and development problems facing Central and Eastern European countries and argues that recent U.S. initiatives

The stems of all the top flowering annual species (gland, balansa, arrowleaf and Persian) had started to elongate in late August and grazing at that stage reduced their ability to

have been reviewed in this paper. The general formulation of risk depending on two parameters: hazard probability and associated consequences has been discussed after

Ala Batli [12] proposed the system that determines the Euclidian distance between core point and neighbour bifurcation points and the results has been evaluated using back